The Food and Drug Administration canceled a meeting about flu vaccine strains scheduled for March 13, according to committee member Paul Offit. Committee members received an email about the cancellation, first reported by Jeremy Faust of Inside Medicine, without further details on rescheduling.

Vaccine makers rely on this meeting to determine which flu strains to include in this year’s vaccine, highlighting its importance, as Offit stated.

Offit emphasized that the meeting is critical for vaccine makers to strategize for the next flu season, noting, ‘It’s an important meeting.